What is Altimmune's price / book?

Altimmune (ALT) reported price / book of 1.4× in Q1 2026.

How has Altimmune's price / book changed year-over-year?

Altimmune's price / book decreased by 47.9% year-over-year, from 2.7× to 1.4×.

What is the long-term trend for Altimmune's price / book?

Over 5 years (2020 to 2025), Altimmune's price / book has grown at a -3.3% compound annual growth rate (CAGR), from 2× to 1.7×.

What does price / book mean?

Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

Altimmune ALT Price / book

Price / book at other companies

Eli LillyLLY

26.3×-20.7×

Merck & Co.MRK

6.5×+1.8×

Madrigal Pharmaceuticals, Inc.MDGL

22.1×+11.8×

Viking TherapeuticsVKTX

7.5×+4.3×

Wave Life SciencesWVE

2.7×-4.6×

Delcath SystemsDCTH

2.9×-2.4×

Other financials

Income statement

See full

Revenue$26.0K+420%

Operating income-$24.2M-11.1%

Net income-$22.6M-15.3%

EPS (diluted)-$0.18+30.8%

Balance sheet

See full

Cash & equivalents$97.6M+98.7%

Total debt$34.8M+14,092%

Total equity$284.0M+99.8%

Total assets$335.6M+113%

Cash flow

See full

Operating cash flow-$20.9M-24.4%

CapEx$21.0K—

Free cash flow-$21.0M—

Valuation

See full

Market cap$558.14M-2.1%

Enterprise value$495.27M-5.0%

P/S13,613.2×-24,380×

Profitability

See full

Operating margin-230,461%-82,087pp

Net margin-214,861%-76,057pp

FCF margin-17,806.8%-110,030pp

Returns & leverage

See full

Return on equity-42.7%-8.7pp

Debt / equity0.1×+0.1×

Current ratio29.6×+13.7×

Where this comes from

Calculated from Altimmune’s reported figures.

market cap/total stockholders equity=1.4×

Based on the most recent quarter.

The official record: Altimmune’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Altimmune's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Altimmune's price / book?: Altimmune (ALT) reported price / book of 1.4× in Q1 2026.
How has Altimmune's price / book changed year-over-year?: Altimmune's price / book decreased by 47.9% year-over-year, from 2.7× to 1.4×.
What is the long-term trend for Altimmune's price / book?: Over 5 years (2020 to 2025), Altimmune's price / book has grown at a -3.3% compound annual growth rate (CAGR), from 2× to 1.7×.
What does price / book mean?: Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.